帕克利塔克塞尔诱导的外周神经病变的药理动力学模型
Yuchen Sun1, Manjunath P Pai1, N Lynn Henry2
1Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.
一个新的药理动力学-药理动力学 (PK-PD) 模型准确地预测了帕克利塔塞尔的化疗诱导的周围神经病变 (CIPN). 这种模型可以帮助个性化帕克利塔塞尔剂量,以减少CIPN并改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 化疗诱导的周围神经病变 (CIPN) 是帕克利塔塞尔的显著剂量限制毒性,影响患者的生活质量.
- 增加的帕克利塔塞尔暴露,以Cmax表示,与较高的CIPN风险相关.
- 目前的剂量策略并不完全考虑到CIPN发展的个体变异性.
研究的目的:
- 开发一个帕克利塔塞尔的药理动力学-药理动力学 (PK-PD) 模型来预测CIPN.
- 评估模型能够为帕克利塔克塞尔治疗提供个性化剂量策略的能力.
- 为了减少癌症患者中CIPN的发生率和严重程度.
主要方法:
- 使用帕克利塔塞尔Cmax和从每周接受帕克利塔塞尔的乳腺癌患者的稀疏采样数据构建了一个PK-PD模型.
- 该模型整合了每周CIPN问卷数据 (CIPN20) 以确定药理动力学终点.
- 通过模拟标准和增强剂量方案下的CIPN发生率,并与临床试验数据 (CALGB C9840) 进行比较,验证了模型性能.
主要成果:
- 一个两部分的PK模型与一个营业额PD模型相结合,包括一个效果区和值,最好地描述了观察到的CIPN数据.
- 该PK-PD模型表现出良好的预测准确性,模拟的CIPN率与标准 (18%对21%) 和增强 (35%对30%) 帕克利塔塞尔治疗方案中的实际率密切匹配.
- 该模型成功地捕获了UMCC2014.002研究中的患者的CIPN发展.
结论:
- 一个新的PK-PD模型有效地描述了与每周服用帕克利塔塞尔相关的CIPN.
- 这种经过验证的模型有可能指导个性化帕克利塔塞尔剂量以减轻CIPN.
- 根据这种PK-PD模型的个性化剂量可能会改善接受帕克利塔塞尔治疗的癌症患者的治疗结果和生活质量.
更多相关视频
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
相关概念视频
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Mechanistic Models: Overview of Compartment Models
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
